PhD Stane Pajk

PhD Stane Pajk
no.: 28861 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
502.41
A''
106.65
A'
317.29
A1/2
351.38
CI10
916
CImax
226
h10
14
A1
1.85
A3
0.94
Data for the last 5 years (citations for the last 10 years) on September 26, 2026; Data for score A3 calculation refer to period 2021-2025 (2021, 2022, 2023, 2024, 2025)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 52  1,140  988  19 
Scopus 50  1,229  1,079  21.58 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry 
Research projects Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. J1-70052  Light-Driven Expansion of Chemical Space for Challenging Targets (LUX: BLI-AS-MS)   3/1/2026 - 2/28/2029  PhD Janez Ilaš   1,783 
2. NK-60002  Development of Dual-Targeting hTOPOII/HDAC Split-and-Mix-PROTAC's   1/1/2026 - 12/31/2028  PhD Janez Ilaš   1,008 
3. N1-0417  Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis (MULTIGAL-8)   3/1/2025 - 9/30/2028  PhD Marko Anderluh   929 
4. J3-50123  Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance   10/1/2023 - 9/30/2026  PhD Martina Hrast Rambaher   2,769 
5. J3-4496  Next-generation adjuvants for mucosal vaccines   10/1/2022 - 9/30/2026  PhD Žiga Jakopin   1,604 
6. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   12/1/2021 - 11/30/2025  PhD Stane Pajk   3,067 
7. J2-3043  Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases   10/1/2021 - 9/30/2025  PhD Slavko Kralj   5,204 
8. J1-1709  Strukturni vpogled v mehanizem tvorbe površine bakterije Clostridium difficile   7/1/2019 - 6/30/2023  PhD Dušan Turk   2,187 
9. J3-1758  Adverse outcome pathway leading to atherosclerosis   7/1/2019 - 6/30/2022  PhD Tilen Koklič   1,667 
10. L1-4039  Predklinični razvoj novih protimikrobnih učinkovin (Slovene)   7/1/2011 - 6/30/2014  PhD Stanislav Gobec   4,736 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2022 - 12/31/2027 PhD Stanislav Gobec   6,297 
2. P1-0060  Experimental biophysics of complex systems and imaging in biomedicine   1/1/2019 - 12/31/2027 PhD Iztok Urbančič   3,517 
3. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,992 
4. P1-0060  Experimental biophysics of complex systems and imaging in biomedicine   1/1/2015 - 12/31/2018 PhD Janez Štrancar   3,366 
5. P1-0060  Experimental biophysics of complex systems   1/1/2009 - 12/31/2014 PhD Igor Serša   4,069 
6. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2009 - 12/31/2014 PhD Danijel Kikelj   6,844 
7. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2004 - 12/31/2008 PhD Danijel Kikelj   6,792 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite